FDA Approved Medical Products for:

Factor VII deficiency

The table(s) below may not be an exhaustive list of drugs or products used to treat this condition. There may be other products available that are not considered orphan products.

Generic Name Coagulation Factor VIIa (Recombinant)
Trade Name
(Manufacturer Name)
NovoSeven® RT
(Novo Nordisk, Inc.)
The FDA has approved this product to be used in this manner.
Treatment of bleeding episodes in patients with Factor VII Deficiency. Treatment and peri-operative management of Glanzmann's thrombasthenia with refractoriness to platelet transfusions, with or without antibodies to platelets.
More Information about this product Drug Information Portal